Clinical Trial Update: Role Of Sensitivity to neuroEndocrine Systems in Social Decisions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating sensitivity to neuroendocrine systems in social decision-making for Borderline Personality Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Borderline Personality Disorder | Phase 4 | Status: WITHDRAWN